Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

References for PMC Articles for PubMed (Select 19812470)

1.

Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.

Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.

Arch Neurol. 2005 Mar;62(3):454-9.

PMID:
15767511
2.

The value of informant reports for assessment and prediction of dementia.

Jorm AF.

J Am Geriatr Soc. 2003 Jun;51(6):881-2. No abstract available.

PMID:
12757582
3.

The value of informant versus individual's complaints of memory impairment in early dementia.

Carr DB, Gray S, Baty J, Morris JC.

Neurology. 2000 Dec 12;55(11):1724-6.

PMID:
11113230
4.

Mixed effect models of longitudinal Alzheimer's disease data: a cautionary note.

Milliken JK, Edland SD.

Stat Med. 2000 Jun 15-30;19(11-12):1617-29.

PMID:
10844723
5.

Modelling mini mental state examination changes in Alzheimer's disease.

Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA.

Stat Med. 2000 Jun 15-30;19(11-12):1607-16.

PMID:
10844722
6.

Analysis of longitudinal data in an Alzheimer's disease clinical trial.

Thomas RG, Berg JD, Sano M, Thal L.

Stat Med. 2000 Jun 15-30;19(11-12):1433-40.

PMID:
10844708
7.

Measuring cognitive change in a cohort of patients with Alzheimer's disease.

Galasko DR, Gould RL, Abramson IS, Salmon DP.

Stat Med. 2000 Jun 15-30;19(11-12):1421-32.

PMID:
10844707
8.

Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer's disease.

Mohs RC, Schmeidler J, Aryan M.

Stat Med. 2000 Jun 15-30;19(11-12):1401-9. Review.

PMID:
10844705
9.

Measurement of progression in Alzheimer's disease: a clinician's perspective.

Gelb DJ.

Stat Med. 2000 Jun 15-30;19(11-12):1393-400. Review.

PMID:
10844704
10.

Can caregivers independently rate cognitive and behavioral symptoms in Alzheimer's disease patients?: A longitudinal analysis.

Ippen CG, Olin JT, Schneider LS.

Am J Geriatr Psychiatry. 1999 Fall;7(4):321-30.

PMID:
10521165
11.

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM.

JAMA. 1997 Oct 22-29;278(16):1349-56.

PMID:
9343467
12.

An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris S.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S33-9.

PMID:
9236950
13.

Treatment of Alzheimer's disease -- searching for a breakthrough, settling for less.

Drachman DA, Leber P.

N Engl J Med. 1997 Apr 24;336(17):1245-7. No abstract available.

PMID:
9110915
14.
15.

Apolipoprotein E and cognitive decline in Alzheimer's disease.

Plassman BL, Breitner JC.

Neurology. 1996 Aug;47(2):317-20. No abstract available.

PMID:
8756999
16.

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

Stern RG, Mohs RC, Davidson M, Schmeidler J, Silverman J, Kramer-Ginsberg E, Searcey T, Bierer L, Davis KL.

Am J Psychiatry. 1994 Mar;151(3):390-6.

PMID:
8109647
17.

Random-effects models for longitudinal data.

Laird NM, Ware JH.

Biometrics. 1982 Dec;38(4):963-74.

PMID:
7168798
18.
19.

Longitudinal change in three brief assessments of SDAT.

Berg G, Edwards DF, Danzinger WL, Berg L.

J Am Geriatr Soc. 1987 Mar;35(3):205-12.

PMID:
3819259
20.

Reliability of the Washington University Clinical Dementia Rating.

Burke WJ, Miller JP, Rubin EH, Morris JC, Coben LA, Duchek J, Wittels IG, Berg L.

Arch Neurol. 1988 Jan;45(1):31-2.

PMID:
3337672
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk